Corporate Responsibility

Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, has today published its fiscal 2023 Corporate Responsibility Report, highlighting positive progress across every pillar of Catalent’s corporate responsibility strategy – People, Environment, and Community. The report also outlines the company’s future commitments as it progresses its mission to help people lead better and healthier lives.

One area of significant progress in fiscal 2023 was Catalent’s efforts to reduce its environmental footprint and address the harmful effects of climate change. A key initiative supporting this progress was the implementation of ISO-certified environmental management systems at 24 Catalent locations, which account for more than 70% of Catalent’s overall energy use.

With new targets approved by the Science Based Targets initiative (SBTi), Catalent is committed to reducing its Scope 1 and 2 greenhouse gas (GHG) emissions by 42% by 2030 from its 2022 baseline. As part of the SBTi targets, Catalent has also committed to ensuring that 70% of supplier emissions will have science-based targets by end of fiscal 2028.

Alessandro Maselli, Catalent’s President and Chief Executive Officer, said: “Our mission to help people live better and healthier lives is made possible not only through our business, but through our actions and commitments to improve the planet and contribute more broadly to society.”

“Building on great progress in fiscal 2023, I am excited to share our expanded commitments to minimize our impact on the environment and build a better planet. I am extremely proud of our team and their ongoing work to build a diverse and inclusive working environment, and a brighter future for our people, shareholders, and the communities we serve.”

In addition to environmental performance, Catalent delivered several key initiatives throughout fiscal 2023 to help assure the quality, safety, and effectiveness of the treatments it develops, manufactures, and supplies for customers and the millions of patients who depend on them. This included the formal launch of The Catalent Way, with new leadership and a greater focus on continuous improvement to deliver consistent, reliable, and sustainable outcomes for clients, patients, and employees.

In fiscal 2023, Catalent continued its investment in cultivating a diverse and inclusive workplace, and was recognized for the second year in a row as a “Best Place to Work for People with Disabilities.”

In fiscal 2023, Catalent’s contribution to STEM education and other important causes remained close to its all-time high of $1.3 million. Catalent’s employees showed up in record numbers to give back to their communities, with colleagues volunteering in 100 projects across its communities as part of the Catalent Month of Service.